A simple, sensitive, selective and reproducible reversed-phase HPLC method was developed for the determination of sophoricoside in rat plasma after intravenous administration. Naringin was successfully used as internal standard (IS) for calibration. The chromatographic separation was accomplished on a reversed-phase C 18 column using acetonitrile-methanol-0.08％ phosphoric acid (8：29：63, v/v/v) as mobile phase with a ‰ow rate of 1.0 ml/min, with UV detection at 260 nm. Plasma samples were injected into the HPLC system after precipitating protein directly by methanol. Good linearity was achieved in the range of 0.0240～48.0 mg/ml (R 2 ＝0.9989). The limit of detection (LOD) and limit of quantiˆcation (LOQ) of this method were 0.0075 mg/ml and 0.0240 mg/ml, respectively. The absolute recoveries of sophoricoside from plasma were 95.8％, 93.2％, 98.0％ at concentrations of 0.0240, 1.92, 15.0 mg/ml. The intra-day and inter-day variabilities were 3.39％～5.78％ and 2.17％～4.72％, respectively. The developed method was successfully applied to the pharmacokinetic study of sophoricoside after intravenous administration of 2.5, 10 and 20 mg/kg in rats.
INTRODUCTION
Sophora japonica L. (Leguminosae), a well-known traditional Chinese medicinal herb, is o‹cially listed in the Chinese Pharmacopoeia. 1) Its fruits have been used as hemostatic agent in traditional Chinese medicine. Pharmacological studies and clinical practices have demonstrated that S. japonica L. has antitumour, anti-fertility and anti-cancer activities 2, 3) and the active constituents of the herb are ‰avonoid and iso‰avonoids components.
Sophoricoside (Genistein-b-glucoside) ( Fig. 1) , a kind of iso‰avone glycoside, containing as much as 0.73％ (w/w) of the total dry weight in the fruit of S. Japonica L. 4) exhibits potent inhibitory eŠects on interleukin-5 (IL-5), 5) IL-3 and IL-6 bioactivities but very weak on granular cell macrophage colony stimulating factors bioactivity. 6,7) Jung et al. 8) reported the structural requirement of sophoricoside for the inhibitory activity of IL-5.
Iso‰avones and glycosides have received much attention because of their health-related and clinical beneˆts such as anti-oxidative activities as well as triggering of natural killer cell activity 9) and of therapeutic eŠects in cancer, angiocardiopathy, osteoporosis and female climacteric syndrome. 10) There were many studies about metabolism of iso‰avones such as genistein and genistin in China and overseas, 11 13) but there was no report about the determination of sophoricoside in biological matrices and pharmacokinetics in vivo to the best of our knowledge.
Wang et al. 14) reported a capillary electrophoresis (CE) method for the determination of sophoricoside which showed promise in the analysis of coumarin compounds in diŠerent herbal plants and its preparations. Although CE has the merits of high sensitivity, good selectivity and high e‹ciency, the application of CE is less widespread than HPLC because its reproducibility is still a big problem. In this study, a robust, sensitive, simple and accurate HPLC method for the determination of sophoricoside in rat plasma using naringin as IS was developed and the pharmacokinetics of sophoricoside in rat in normal physiological conditions were also investigated at three diŠerent doses of 2.5, 10 and 20 mg/kg after intravenous administration for theˆrst time, which provide the theoretical foundation and reference for the safe and reasonable clinic exploitation of sophoricoside. 
EXPERIMENTAL

Chemicals and Reagents
Sophoricoside was supplied by National Institute for the Control of Pharmaceutical and Biological Products (Beijing, China). Naringin (IS) was obtained from Fluka Chemie AG CH-9470 (Switzerland). Methanol and acetonitrile (HPLC grade) were obtained from Fisher Chemical Company (Canada). Water was prepared by ultra pure water system (UPA, Chongqing, China). All other chemicals were of reagent grade, and were used without further puriˆcation.
Liquid Chromatography HPLC determinations were performed with a Shimadzu model 10 Avp liquid chromatographic system (Tokyo, Japan), consisting of a LC-10AT pump and an UV/Vis detector (SPD-10A). The system was controlled by a system controller (SCL-10A) and a personal computer. The analytical column was a Diamonsil C 18 column (150 ×4.6 mm, 5 mm) from Dikma Technologies. The isocratical elution with a mobile phase of acetonitrilemethanol-0.08％ phosphoric acid (8：29：63, v/v/ v) was used at a ‰ow rate of 1.0 ml/min for the separation of analytes. The analytes were monitored at the UV wavelength of 260 nm.
Preparation of Calibration Standards Sophoricoside was dissolved in methanol (0.240 mg/ml) as stock solution. Working standards were prepared freshly by diluting the stock solution with methanol with concentrations from 0.0240 to 48.0 mg/ml. A working IS solution of 24.0 mg/ml was made by dissolving naringin with methanol. All solutions were stored at 4°C before use.
Plasma standard samples for calibration were prepared daily by spiking 20 ml blank rat plasma with 40 ml working standard solutions to achieve concentrations in the range of 0.0240～48.0 mg/ml. Quality control (QC) samples were independently prepared at concentrations of 0.0240, 1.92 and 15.0 mg/ml in the same manner as the plasma sample for calibration. Then, all the calibration and QC samples were extracted after 20 ml IS solution was added to them by the method described in the sample preparation.
Sample Preparation
The IS solution (20 ml) and 40 ml of methanol (protein precipitant and extraction solvent) were added to plasma samples (20 ml). Extraction was conducted by vortexing vigorously for 2 min and centrifuged at 12 000 rpm for 10 min. The supernatant was transferred to a glass tube. A 20 ml aliquot of the supernatant was injected into the HPLC system.
Recovery and Stability of Sophoricoside Samples
Recoveries of sophoricoside were assessed (n＝6) at 15.0, 1.92 and 0.0240 mg/ml. The recoveries were determined by comparing the peak area ratio of sophoricoside to naringin in plasma with that in methanol at the same concentration. The ambient stability and freeze-thaw stability of sophoricoside in rat plasma were assessed using the QC samples of three diŠerent concentrations (0.0240, 1.92 and 15.0 mg/ml). The ambient stability was assessed by leaving the QC samples at room temperature for 24 h. The freeze-thaw stability was assessed over three cycles thawed at room temperature and refrozen at -20°C.
Precision and Accuracy
The intra-day precision and accuracy of the assay were determined within one day by analyzing six replicates of QC samples at concentrations of 15.0, 1.92 and 0.0240 mg/ ml. The inter-day precision and accuracy were estimated from the results of assays of QC samples of six diŠerent days within one week.
Pharmacokinetic Studies Male Sprague-Dawley rats (250 ± 20 g) were obtained from Laboratory Animal Center of Sichuan University. The animal experiments in this study were conducted in accordance with the Guidelines for the Care and Use of Laboratory Animals, and approved by the Institutional Animal Care and Use Committee of Sichuan University.
The rats were allowed to freely access to food and water under the controlled temperature at 25±1°C and fasted overnight before use. 0.5 ml of sophoricoside solubilized in N,N-dimethylformamide/isotonic Na chloride(60：40, v/v ) were given to the rats through the tail vein at three diŠerent doses (2.5, 10, 20 mg/kg, respectively) by mathematical conversion of doses between diŠerent species (from human to rat) according to the Chinese Pharmacopeia. Serial blood samples (0.3 ml) were obtained from fossa orbitalis into heparinized tubes. Plasma samples were collected at 0, 10, 30, 60, 120, 180, 300 min for low dose after drug administration. They were collected at 0, 10, 60, 120, 180, 300, 420 min for middle dose and at 0, 10, 60, 120, 180, 300, 420, 480 min for high dose, respectively. Plasma samples were obtained following centrifugation at 4000 rpm for 20 min and were stored at -20°C until analysis.
The pharmacokinetic parameters were determined by using PK software Drug and Statistics (Version 2.1.1, China). The pharmacokinetic parameters estimated in this study were as follows: the area under the plasma concentration-time curve from 0 to ∞ (AUC 0-∞ ), elimination half-life (t 1/2 ), volume of distribution (Vd), clearance (Cl) and mean residence time(MRT).
RESULTS AND DISCUSSION
Selection of IS
Due to the high accuracy requirement for biological samples analysis, assay method with a suitable IS is often adopted. An ideal IS should have similar chromatographic and spectral properties as the compounds to be analyzed. Several substances had been tried such as baicalin, jasminoidin and naringin in this study. Naringin was chosen at last since it presented a good peak shape, satisfactory resolution under the HPLC conditions applied. In addition, the suitability of naringin as IS was further proven by recovery studies (95.8％, RSD
＝1.33％, n＝6).
HPLC Method Validation
In the current study, an HPLC method was optimized and validated for the quantitative determination of sophoricoside in rat plasma. Typical chromatograms of blank plasma, spiked plasma and plasma sample are shown in Fig. 2 . The chromatogram showed a clear and good separation of the peaks, and the retention times were 10.6 min for sophoricoside and 8.4 min for IS, respectively. The resolution of naringin to sophoricoside was 3.21 and no interfering peaks derived from endogenous substance were observed in the blank plasma at the retention time of the analytes of interest.
The calibration curve for sophoricoside exhibited a good linear response within the range of concentrations from 0.0240～48.0 mg/ml (y＝0.0448x-0.0067, R 2 ＝0.9989, y is the peak area ratio of sophoricoside to the IS, and x is the plasma concentration of sophoricoside). The LOD for this method deˆned as signal-to-noise ratio of 3：1 was 0.0075 mg/ ml and the LOQ deˆned as the lowest concentration of spiked plasma samples that can be determined with su‹cient precision and accuracy, i.e., relative standard deviation (RSD) less than 20％ and relative error (RE) of -20 to 20％. The LOQ was estimated as 0.0240 mg/ml.
In order to optimize the sample preparation method, a single-step liquid-liquid extraction with diŠerent solvents (include chloroform, petroleum ether, ethyl ether, ethyl acetate) and precipitating protein directly with diŠerent solvents (include methanol, ethanol, acetonitrile) and the volume ratio of sample to solvent had been investigated to compare recoveries of sophoricoside from rat plasma sample. Methanol precipitating protein was adopted because it had high absolute recovery without any signiˆcant interference and was simple relatively. From the experiment, we found that the recoveries were the same generally when the volume ratios of plasma sample to methanol 1：2, 1：3 and 1：4 (v/v) were used to precipitate protein. Considering the level of cleaness and diluted volume, 1：3 (v/v) was adopted to precipitate protein. This method was simple and small volume of plasma sample was required. The mean absolute recoveries of sophoricoside at three concentrations were 95.8％, 93.2％ and 98.0％, respectively. The results are shown in Table 1 .
The intra-day and inter-day precision calculated by replicate assays of sophoricoside in rat plasma were less than 6％ over a wide range of sophoricoside concentration. The accuracy during replicate assays varied between 94％ and 103％. Precision and accuracy studies indicated that the developed HPLC method was reproducible and accurate ( Table 2) .
Stability investigation (Table 3) demonstrated that the concentrations of sophoricoside in processed samples had no signiˆcant diŠerence to nominal values within 24 h at 25°C and between the three freeze-thaw cycles (room temperature to -20°C). These indicated that the analyte in rat plasma was stable for up to 24 h at 25°C with the maximal loss of 2.9％ and was stable over at least three freeze-thaw cycles with no signiˆcant loss (10.4％).
Pharmacokinetic Application The plasma concentrations of sophoricoside after intravenous administration in rats were quantitatively determined by the developed HPLC method. The pharmacokinetic parameters (Table 4) were determined byˆtting pharmacokinetic models to the plasma concentrationtime proˆles (Fig. 3) for each rat after intravenous dosing. From the results of kinetic analysis, a onecompartment model was proposed. From Table 4 , it can be seen that with the increase of dose, AUC 0→∞ increased proportionally, while MRT, t 1/2 and Cl kept almost the same. Thus, the composite pharmacokinetics wasˆrst order process in the range of dose examined.
CONCLUSIONS
A sensitive, speciˆc, accurate and reproducible reversed-phase HPLC method for the determination of sophoricoside in rat plasma was developed which had been successfully applied to the study of pharmacokinetics of sophoricoside in rat for theˆrst time. This method can be available for large number of biological samples very e‹ciently. Further studies are ongoing in our laboratory to further characterize the absorption and metabolism of sophoricoside.
